tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
IDXX is currently covered by 9 analysts with an average price target of $559.61. This is a potential upside of $67.91 (13.81%) from yesterday's end of day stock price of $491.7.
IDEXX Laboratories's activity chart (see below) currently has 97 price targets and 106 ratings on display. The stock rating distribution of IDXX is 62.5% BUY and 37.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 66.5% with an average time for these price targets to be met of 121.8 days.
Highest price target for IDXX is $575, Lowest price target is $420, average price target is $538.75.
Most recent stock forecast was given by JONATHAN BLOCK from STIFEL on 14-Apr-2025. First documented stock forecast 24-Jun-2014.
IDEXX Laboratories is a global leader in veterinary diagnostic testing and services, as well as water quality testing solutions. The company primarily serves the companion animal veterinary market, as well as livestock and poultry producers, dairy farmers, and the biomedical research community.
IDEXX offers a wide range of diagnostic products and services, including point-of-care veterinary diagnostic products, veterinary reference laboratory diagnostic and consulting services, and practice management and diagnostic imaging systems and services for veterinarians. The company also provides health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for the biomedical research community.
In addition to veterinary diagnostic products, IDEXX also offers diagnostic and health-monitoring products for livestock, poultry, and dairy producers. These products include water testing products that test for various microbiological contaminants, as well as point-of-care electrolytes and blood gas analyzers.
During the COVID-19 pandemic, IDEXX also developed an RT-PCR test kit for human COVID-19 testing, called OPTI SARS-CoV-2 RT-PCR test kit.
IDEXX has a broad range of testing capabilities, including in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers, as well as SNAP rapid assays test kits. The company also offers veterinary software and services for independent veterinary clinics and corporate groups.
The company was founded in 1983 and is headquartered in Westbrook, Maine.
Currently out of the existing stock ratings of IDXX, 20 are a BUY (62.5%), 12 are a HOLD (37.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$420
$-51.9 (-11.00%)
$500
26 days ago
(14-Apr-2025)
13/14 (92.86%)
$15.35 (3.79%)
147
Hold
$510
$38.1 (8.07%)
$435
3 months ago
(10-Feb-2025)
7/9 (77.78%)
$45.09 (9.70%)
58
Hold
$535
$63.1 (13.37%)
$565
3 months 6 days ago
(04-Feb-2025)
4/7 (57.14%)
$69.97 (15.05%)
217
Buy
$520
$48.1 (10.19%)
$481
3 months 6 days ago
(04-Feb-2025)
2/11 (18.18%)
$54.97 (11.82%)
86
Buy
$500
$28.1 (5.95%)
$580
6 months 9 days ago
(31-Oct-2024)
10/12 (83.33%)
$93.08 (22.87%)
129
What is IDXX (IDEXX Laboratories) average time for price targets to be met?
Which analyst has the current highest performing score on IDXX (IDEXX Laboratories) with a proven track record?
Which analyst has the most public recommendations on IDXX (IDEXX Laboratories)?
Which analyst is the currently most bullish on IDXX (IDEXX Laboratories)?
Which analyst is the currently most reserved on IDXX (IDEXX Laboratories)?
